Concepedia

Author

Mark Penney

UCB Pharma (United Kingdom)

Also Known As

M Penney, M. Penney, MD Penney, Mark Penney, Mark S Penney

30

Publications

1.5K

Citations

16

H-Index

29

Concepts

All Affiliations

UCB Pharma (United Kingdom)Derriford HospitalAstraZeneca (United Kingdom)AstraZeneca (Sweden)AstraZeneca (United States)
MP

About

Mark Penney is an author at UCB Pharma (United Kingdom) specializing in medicine, immunology, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

106

2

Health Sciences

1

1

10

3

Diabetes

1

1

19

4

Gastroenterology

1

1

20

5

Health Informatics

1

1

57

Mark Penney

×

16

Publications

1.4K

Citations

15

H-Index

YearCitations

Prevalence of lymphoreticular prion protein accumulation in UK tissue samples

David A. Hilton, Azra C. Ghani, Lisa Conyers,

The Journal of Pathology

2004

441

Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn’s Disease: A Phase 2a Study

Bruce E. Sands, Jingjing Chen, Brian G. Feagan,

Gastroenterology

2017

273

A randomised, placebo-controlled trial of anti–interleukin-1 receptor 1 monoclonal antibody MEDI8968 in chronic obstructive pulmonary disease

Peter M.A. Calverley, Sanjay Sethi, Michelle Dawson,

Respiratory Research

2017

91

Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction

Elizabeth England, D. Gareth Rees, Ian C. Scott,

Scientific Reports

2023

89

Structural and functional characterization of a specific antidote for ticagrelor

Andrew Buchanan, Philip M. Newton, S. KENNETH PEHRSSON,

Blood

2015

88

Expression of hypoxia‐inducible factor 1α in tumours of patients with glioblastoma

K. L. Søndergaard, David A. Hilton, Mark Penney,

Neuropathology and Applied Neurobiology

2002

85

Applications of Quantitative Systems Pharmacology in Model‐Informed Drug Discovery: Perspective on Impact and Opportunities

Erica L. Bradshaw, Mary E. Spilker, Richard Zang,

CPT Pharmacometrics & Systems Pharmacology

2019

85

Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt–Jakob disease

David A. Hilton, Judit Sutak, Maynard Smith,

Journal of Clinical Pathology

2004

74

Best Practices to Maximize the Use and Reuse of Quantitative and Systems Pharmacology Models: Recommendations From the United Kingdom Quantitative and Systems Pharmacology Network

L. Cucurull-Sanchez, Michael J. Chappell, Vijayalakshmi Chelliah,

CPT Pharmacometrics & Systems Pharmacology

2019

57

Histological indicators of prognosis in glioblastomas: retinoblastoma protein expression and oligodendroglial differentiation indicate improved survival

D. A. Hilton, Mark Penney, Louis Pobereskin,

Histopathology

2004

36

Page 1